Related Experiment Video
Updated: Oct 6, 2025
In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
Published on: September 7, 2022
Aptamers Against COVID-19: An Untested Opportunity
Annekathrin Haberland1, Johannes Müller2
1Berlin Cures GmbH, Robert-Rössle-Str. 10, 13125 Berlin, Germany.
Aptamers offer a promising therapeutic approach for COVID-19 and long-COVID due to their multiple modes of action. This strategy addresses the limitations of single-action drugs in treating complex viral diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The development of effective COVID-19 treatments has been challenging, with single-mode-of-action drugs showing limited success.
- COVID-19 is a complex disease requiring multifaceted therapeutic strategies beyond direct antivirals or anti-inflammatories.
Purpose of the Study:
- To review current research on aptamer development for COVID-19 and long-COVID treatment.
- To highlight the potential of aptamers' multiple modes of action for complex diseases.
Main Methods:
- Literature review of aptamer-based therapeutic strategies for COVID-19.
- Analysis of aptamer capabilities, focusing on bundled therapeutic effects.
Main Results:
- Aptamers demonstrate potential as therapeutic agents for COVID-19 and long-COVID.
- The multi-action capability of aptamers offers a unique advantage over traditional single-action drugs.
Conclusions:
- Aptamers represent a promising avenue for novel COVID-19 therapies.
- The bundled, multiple modes of action of aptamers are well-suited for addressing the complexity of COVID-19 and long-COVID.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
08:21Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025